TD Cowen Upgrades Pacira Pharmaceuticals (PCRX) to Outperform, 'Anticipate Sentiment Reversal In 2H23'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. ROST
5. BILL
6. WMT
7. ADI
8. MRK
9. MRNA
10. LOW

Go back to TD Cowen Upgrades Pacira Pharmaceuticals (PCRX) to Outperform, 'Anticipate Sentiment Reversal In 2H23'

Pacira Pharmaceuticals (PCRX) PT Lowered to $68 at RBC Capital

August 2, 2023 4:06 PM EDT

RBC Capital analyst Daniel Busb lowered the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $68.00 (from $70.00) while maintaining a Outperform rating.... More

Pacira Pharmaceuticals (PCRX) PT Lowered to $55 at Truist Securities

August 2, 2023 1:13 PM EDT

Truist Securities analyst Gregory D. Fraser lowered the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $55.00 (from $60.00) while maintaining a Buy rating.... More